Introducing RSP’s patented GlucoBeam™ TGM™ technology
RSP’s patented technology advances the field by light years
RSP has developed and clinically verified a non-invasive technology by applying new innovation to a well-understood principle
This all-in-one technology system combines Raman spectroscopy and RSP-proprietary Critical Depth technologies to create touch glucose monitoring
User touches the screen with base of thumb
and a beam of light shines on the skin
Light scattered from the skin is collected and processed using artificial intelligence (AI)
Glucose measurement is displayed within a minute
Apparatus patent covering Critical Depth measurements enabling sustainable calibration and thus practical use.
Method patent claiming the use of primary spectral data for gauging quality of measurement.
Apparatus patent claiming reduced size spectrometer technology. Enabling overall reduced footprint and future lowering of COGS.
Our highly skilled team have advanced the technological application of Raman spectroscopy to be used to non-invasively measure relevant molecules in human tissue.
These advancements are the result of a decade long R&D and pre-clinical study program during which we refined Raman technology, focusing on improving the optical system, electronics, and data analysis algorithms.
Furthermore, we have carefully developed the know-how of in-vivo measurements required to:
In the process, we have discovered and patented fundamental aspects of Raman detection of glucose and other substances in human tissue. This removes the dependence of signal calibration on the probe position, allowing for unprecedented performance.